Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer = 2-year follow-up results at a single institution in Korea

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of this study was to examine 2-year follow-up results of cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis (PC) of colorectal cancer.
Methods: We performed 54 cases of CRS and IPC in 53 patients with PC of colorectal cancer from December 2011 to December 2013. We collected data prospectively and analyzed the grade of PC, morbidity and mortality, and short-term follow-up (median, 10 months; range, 2–47 months) results.
Results: Mean peritoneal cancer index (PCI) was 15 (range, 1–35), and complete cytoreduction was possible in 35 patients (64.8%). Complications occurred in 25 patients (46.3%) and mortality occurred in 4 patients (7.4%). Excluding the 4 mortalities, 17 patients out of 49 patients (31.5%) were alive at the time of the last follow-up and the overall median survival was 10.3 months. Patients with complete cytoreduction had a median survival of 22.6 months, which was significantly longer than the median survival of 3.5 months for patients without complete cytoreduction (P < 0.001). PCI grade, CCR grade, cell type, and postoperative chemotherapy were significant prognostic factors by univariate analysis. Positive independent prognostic factors by multivariate analysis included PCI grade and postoperative chemotherapy.
Conclusion: CRS and IPC increased the survival of patients with low PCI and postoperative systemic chemotherapy was mandatory. However, this combined therapeutic approach showed high rate of complications and mortality. Therefore, this aggressive treatment should be performed in only selected patients by considering the general condition of the patient and the extent of PC.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Roviello F., "Treatment of peritoneal carcinomatosis with cyto reductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments" 20 : e38-e54, 2011

2 Kusamura S., "The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs" 21 : 559-576, 2012

3 Chua TC., "Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? : a systematic review of morbidity and mortality" 249 : 900-907, 2009

4 Verwaal VJ., "Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemo therapy and palliative surgery in pa tients with peritoneal carcinomatosis of colorectal cancer" 21 : 3737-3743, 2003

5 Cavaliere F., "Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcino matosis treated with cytoreductive sur gery combined with hyperthermic intra peritoneal chemotherapy: Italian multi center study S.I.T.I.L.O" 37 : 148-154, 2011

6 Sugarbaker PH, "Peritonectomy procedures" 221 : 29-42, 1995

7 Elias D., "Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy : retrospective analysis of 523 patients from a multicentric French study" 28 : 63-68, 2010

8 Lungoci C., "Multimodality treatment strategies have changed prognosis of peritoneal metastases" 8 : 67-82, 2016

9 Chua TC., "Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intra peritoneal chemotherapy for patients with colorectal peritoneal carcinomatosis : a multicenter study" 18 : 1560-1567, 2011

10 Mirnezami R., "Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone" 111 : 1500-1508, 2014

11 Glehen O., "Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal car cinomatosis from colorectal cancer : a multi-institutional study" 22 : 3284-3292, 2004

12 Esquivel J., "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology" 14 : 128-133, 2007

13 Franko J., "Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis" 116 : 3756-3762, 2010

14 Weber T., "Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carci nomatosis from colorectal cancer" 11 : 167-176, 2012

15 Turaga K., "Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemo therapy(HIPEC)in colorectal cancer pa tients in the United States" 21 : 1501-1505, 2014

16 Canda AE., "Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy" 20 : 1082-1087, 2013

17 Elias D., "Comparison of two kinds of intra peritoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis" 14 : 509-514, 2007

18 임준석, "Comparison of CT and 18F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma" 대한영상의학회 7 (7): 249-256, 2006

19 Jacquet P., "Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis" 82 : 359-374, 1996

20 Esquivel J., "American Society of Peri toneal Surface Malignancies opinion state ment on defining expectations from cyto reductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer" 110 : 777-778, 2014

21 Cao C., "A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin" 16 : 2152-2165, 2009

22 Verwaal VJ., "8-year follow-up of randomized trial : cytoreduction and hyperthermic intraperitoneal chemo therapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer" 15 : 2426-2432, 2008

23 Pfannenberg C., "(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cyto re ductive surgery and hyperthermic intra peritoneal chemotherapy" 16 : 1295-1303, 2009